Bioprocessing Application Notes & Case Studies

  1. A Novel Cell-Based Assay For Ubiquitin Drug Discovery 7/29/2025

    Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.

  2. High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells 7/29/2025

    High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.

  3. Risk Assessment Services Align With FDA Guidance For Gene-Edited Human Gene Therapy Products 7/29/2025

    Navigate the FDA's gene therapy guidelines with advanced risk assessment strategies. Optimize gene editing and ensure regulatory alignment for safer, more effective therapies.

  4. Mammalian Display Method For The Development Of Enhanced Affinity TCR-Based Biologics 7/29/2025

    Discover how mammalian display enhances T cell receptor-based cancer therapies. This method improves antigen affinity and reduces immunogenicity for more effective treatments.

  5. Electroporation Enables Efficient Antibody Discovery By Mammalian Display 7/29/2025

    Achieve greater sequence diversity and library coverage in antibody discovery. Learn about an approach enables reproducible and scalable transfections, leading to the identification of better antibody candidates.

  6. Development Of A Landing-Pad CHO Cell Line For Mammalian Display 7/29/2025

    A single-site "landing pad" CHO cell line simplifies the creation of mammalian display libraries, enabling consistent, single-copy integration of target sequences for biologic drug discovery.

  7. Complementing Routine Peptide Monitoring 7/29/2025

    Discover how to enhance your peptide analysis by integrating UV and mass spectral data into a single, streamlined workflow to boost data confidence and lab efficiency.

  8. LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting 7/29/2025

    Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.

  9. Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs 7/29/2025

    GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.

  10. Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS 7/29/2025

    Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.